Literature DB >> 9593154

Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.

M Sörberg1, H Hanberger, M Nilsson, A Björkman, L E Nilsson.   

Abstract

We have studied initial killing, morphological alterations, the frequency of occurrence, and the selective growth of resistant subpopulations of Helicobacter pylori during exposure to amoxicillin, clarithromycin, or metronidazole by bioluminescence assay of intracellular ATP levels, microscopy, and a viable count assay. We found an induction of spheroplasts and a decrease in intracellular ATP levels after 21 h of exposure to high concentrations of amoxicillin. During clarithromycin exposure the onset of a decrease in intracellular ATP levels started after prolonged incubation, and with the highest concentration of clarithromycin an induction of coccoid forms was seen after 68 h. Metronidazole exposure resulted in the strongest initial decrease in intracellular ATP levels, and coccoid forms were seen after 21 h of exposure to high concentrations of metronidazole. Amoxicillin caused a low-level increase in resistant subpopulations, which indicates a need for surveillance of the amoxicillin susceptibility of H. pylori in order to detect decreasing susceptibility. No increase in the numbers of resistant subpopulations was demonstrated during clarithromycin exposure. Metronidazole selected resistant subpopulations, which caused high-level resistance in H. pylori.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593154      PMCID: PMC105783          DOI: 10.1128/AAC.42.5.1222

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Role of metronidazole resistance in therapy of Helicobacter pylori infections.

Authors:  H Rautelin; K Seppälä; O V Renkonen; U Vainio; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

2.  One week eradication regimen for Helicobacter pylori.

Authors:  R P Logan; P A Gummett; J J Misiewicz; Q N Karim; M M Walker; J H Baron
Journal:  Lancet       Date:  1991-11-16       Impact factor: 79.321

3.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

4.  Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

5.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

6.  Factors influencing the eradication of Helicobacter pylori with triple therapy.

Authors:  D Y Graham; G M Lew; H M Malaty; D G Evans; D J Evans; P D Klein; L C Alpert; R M Genta
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

7.  Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.

Authors:  E Hentschel; G Brandstätter; B Dragosics; A M Hirschl; H Nemec; K Schütze; M Taufer; H Wurzer
Journal:  N Engl J Med       Date:  1993-02-04       Impact factor: 91.245

8.  Proposed mechanism for metronidazole resistance in Helicobacter pylori.

Authors:  G Cederbrant; G Kahlmeter; A Ljungh
Journal:  J Antimicrob Chemother       Date:  1992-02       Impact factor: 5.790

9.  Cure of duodenal ulcer associated with eradication of Helicobacter pylori.

Authors:  E A Rauws; G N Tytgat
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

10.  Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.

Authors:  J A Armstrong; S H Wee; C S Goodwin; D H Wilson
Journal:  J Med Microbiol       Date:  1987-12       Impact factor: 2.472

View more
  9 in total

1.  Stable and unstable amoxicillin resistance in Helicobacter pylori: should antibiotic resistance testing be performed prior to eradication therapy?

Authors:  S R Han; S Bhakdi; M J Maeurer; T Schneider; S Gehring
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

2.  Antimicrobial susceptibilities of Helicobacter pylori isolates under microaerophilic atmospheres established by two different methods.

Authors:  I Kobayashi; H Muraoka; T Saika; M Nishida; T Fujioka; M Nasu
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

3.  Competition of various beta-lactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.

Authors:  R Paul; S Postius; K Melchers; K P Schäfer
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

5.  Antimicrobial activity of Sapindus mukorossi and Rheum emodi extracts against H pylori: In vitro and in vivo studies.

Authors:  Mohammed Ibrahim; Aleem-A Khan; Santosh-K Tiwari; Mohammed-Aejaz Habeeb; M-N Khaja; C-M Habibullah
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

6.  Characterization of an In vitro-selected amoxicillin-resistant strain of Helicobacter pylori.

Authors:  C R DeLoney; N L Schiller
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

7.  Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population.

Authors:  Sook-Yin Lui; Khay-Guan Yeoh; Bow Ho
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori?

Authors:  Paweł Krzyżek
Journal:  Front Cell Infect Microbiol       Date:  2021-04-26       Impact factor: 5.293

9.  Geranylgeranylacetone selectively binds to the HSP70 of Helicobacter pylori and alters its coccoid morphology.

Authors:  Ewa Grave; Shin-ichi Yokota; Soh Yamamoto; Arisa Tamura; Takako Ohtaki-Mizoguchi; Kenji Yokota; Keiji Oguma; Kazuhiko Fujiwara; Nobuaki Ogawa; Tomoya Okamoto; Michiro Otaka; Hideaki Itoh
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.